By Kate Kelland LONDON (Reuters) - Experimental Ebola drugs including compounds from Mapp Biopharmaceutical, Sarepta and Tekmira will be tested in affected West African states for the first time in a bid to fast-track trials, the Wellcome Trust said on Tuesday. Announcing a 3.2 million pound ($5.25 million) grant for the work, the global health charity said the money would "enable multiple partners around the world to quickly establish clinical trials at existing Ebola treatment centers". ...
Read More http://ift.tt/1slb7EF
No comments:
Post a Comment